177Lu-PSMA-617
Novartis
['crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
efficacy of systemic therapy following [177lu] lu-psma in patients with #mcrpc. presented by . #gu23 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology